In July 2017 the International Association of Athletics Federations (IAAF) has reported an anti-doping rule violation against the Kenyan Athlete Eliud Magut after his samples tested positive for the prohibited substance 19-norandrosterone (Nandrolone).
After notification a provisional suspension was ordered. The Athlete filed a statement in his defence and he was heard for the IAAF Disciplinary Tribunal.
The Athlete admitted the violation, stated that it was not intentional and accepted the test result. He explained that he had received injections in a sports club for his libido condition.
The IAAF contended that the Athlete failed to establish the source of the prohibited substance and that his explanation was unsubstantiated and lacked credibility. Also the IAAF asserted that the Athlete knew there was a significant risk in receiveing the injections and his conduct in allowing a person who was unknown to him at the time to administer such injections showed a complete manifest disregard for that risk.
The Tribunal finds that the result showed the presence of the prohibited substance in the Athlete’s sample and accordingly that he committed an anti-doping rule violation. The Tribunal concludes that it is not satisfied that the Athlete’s explanation is more likely than not to be true. The Tribunal deems that he failed to establish that this violation was not intentional and his conduct leads to a clear case of an indirect intentional violation under the Rules.
Therefore the Disciplinary Tribunal decides on 15 June 2018 to impose a 4 year period of ineligibility on the Athlete starting on the date of the provisional suspension, i.e. on 14 July 2017.
